Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EBT Medical is a clinical-stage healthcare company focused on developing non-invasive neuromodulation therapies for pelvic health disorders. The company's primary product is a wearable device designed to treat overactive bladder (OAB) by stimulating the saphenous nerve, offering a discreet and drug-free alternative to traditional treatments. By leveraging a unique physiological pathway, EBT Medical aims to provide patients with a home-based solution that avoids the side effects of systemic medications and the invasiveness of surgical implants. The company is currently advancing its lead program through clinical trials to validate the safety and efficacy of its proprietary technology. EBT Medical is backed by prominent life science investors and is positioned to disrupt the multi-billion dollar pelvic health market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EBT Medical.